Advancing Specialty Pharmacy and Infusion Strategies

Review takeaways from the executive session sponsored by McKesson at Becker’s 12th Annual CEO + CFO Roundtable.

Date

January 21, 2025

Read Time

2 minutes

At the recent Becker’s 12th Annual CEO + CFO Roundtable, held from November 11 to 14, McKesson hosted a lively and in-depth roundtable on the current landscape, challenges, and strategies related to specialty pharmacy and infusion services within various health systems. Our expert participants – Prateek Bhatia, VP of Intrafusion; Lindsey DeMarrais, Managing Consultant; and Chris Wahlenmaier, Sr. Director of Marketing – engaged with 16 executive participants, including 10 c-suite executives, representing leading health systems from across the country.

The session explored strategic goals, current initiatives, and challenges in specialty pharmacy and infusion services, focusing on financial management, technology, partnerships, and emerging trends. We gained valuable insights into optimizing financial strategies, leveraging technology for revenue cycle management, and forming strategic partnerships to improve service delivery. This collaborative effort demonstrates our dedication to helping customers achieve more in the business of pharmacy.

For key takeaways and actionable insights, click here to read the full roundtable recap.

Subscribe Now

To learn how McKesson can help health systems achieve more, sign up to have the Prescribed Perspectives newsletter delivered directly to your inbox.

Brittany Ulrich, PharmD, CSP, BCBBS, examines how limited distribution drugs and payer requirements push specialty prescriptions outside the organization, eroding visibility into patient outcomes, and how Biologics by McKesson helps health systems expect more when it comes to maintaining care continuity.

Aerial view of a large warehouse complex with loading docks, trucks and intersecting roads.

Case Study: How McKesson’s Winter-Storm Playbook Kept Specialty Drugs Moving

Expect more for the business of pharmacy with a pressure-tested, multi-layered business continuity strategy.

Researcher in a laboratory looks through shelving lined with containers and supplies.

What You Should Know About the CMS Proposed 340B Payment Change

Dr. Andrew Wilson, B.S., Pharm.D., FASHP, reflects on the proposed CY 2027 OPPS rule for several outpatient drugs purchased through the 340B program, and the next phase of specialty drug margin management for the business of pharmacy.

Open laptop beside a stack of tabbed documents in a binder on a desk, with a softly blurred office background.

Top Prescribed Perspectives Reads for August

The top three Prescribed Perspectives articles most read by health systems in August.

Business professionals greet with a handshake in a modern office while colleagues stand nearby during a networking conversation.

Upcoming Event: inSPire 2026

Connect with McKesson at inSPire to help shape the future of specialty pharmacy

Healthcare professional and colleague review information on a tablet in a clinical setting.

Where Does Your Health System Fall on the Specialty and Infusion Growth Journey?

With our assessment, benchmark your progress across the specialty and infusion journey to achieve more for the business of pharmacy.

Advancing Specialty Pharmacy and Infusion Strategies

Related Stories

Related Tags